Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2023

Open Access 01-12-2023 | Arterial Diseases | Research

Triglyceride-glucose index is associated with severe obstructive coronary artery disease and atherosclerotic target lesion failure among young adults

Authors: Shalaimaiti Shali, Lingfeng Luo, Kang Yao, Xiangdong Sun, Hongyi Wu, Shuning Zhang, Lili Xu, Wei Gao, Jianxuan Li, Juying Qian, Yan Zheng, Yuxiang Dai, Junbo Ge, the GRAND investigators

Published in: Cardiovascular Diabetology | Issue 1/2023

Login to get access

Abstract

Background

Early diagnosis and treatment effectiveness of early-onset coronary artery disease (EOCAD) are crucial, and non-invasive predictive biomarkers are needed for young adults. We aimed to evaluate the usefulness of the triglyceride-glucose (TyG) index, a novel marker of insulin resistance, in identifying young CAD patients and predicting their risk of developing target lesion failure (TLF).

Methods

We recruited EOCAD patients (luminal narrowing ≥ 70%) and controls free from CAD (luminal narrowing < 30%), both aged 45 years or younger, from 38 hospitals in China between 2017 and 2020. EOCAD patients who underwent successful percutaneous coronary intervention were followed for incident TLF. TyG index was defined as Ln [fasting triglyceride (mg/dL) × fasting blood glucose (mg/dL)/2]. We used logistic regression and Cox proportional hazards modeling to evaluate the association of TyG index with prevalent EOCAD and incident TLF, respectively. The discriminatory ability of TyG index was assessed by the area under the receiver-operating characteristic curve (AUC).

Results

Among the included 1513 EOCAD patients (39.6 ± 4.4 years, 95.4% male) and 1513 age-matched controls (39.0 ± 4.4 years, 46.4% male), TyG index was positively associated with the prevalence of EOCAD (adjusted odds ratio: 1.40, 95% confidence interval [CI] 1.23–1.60, per standard deviation [SD] increase in TyG index). The addition of TyG index to an empirical risk model provided an improvement in diagnostic ability for EOCAD, with a net reclassification improvement of 0.10 (95% CI 0.03–0.17, p = 0.005). During a medium of 33 month (IQR: 31–34 months) follow-up, 43 (3.3%) patients experienced TLF. Multivariate Cox regression model revealed that TyG index was an independent risk factor for TLF (adjusted hazard ratio [HR]: 2.410, 95% CI 1.07–5.42 comparing the top to bottom TyG index tertile groups; HR: 1.30, 95% CI 1.01–1.73, per SD increase in TyG index). Compared with a model of conventional risk factors alone, the addition of the TyG index modestly improved the AUC (0.722–0.734, p = 0.04) to predict TLF.

Conclusions

TyG index is positively associated with prevalent EOCAD and incident TLF. TyG index appeared to be a valuable component of future efforts to improve CAD risk stratification and TLF outcome prediction among young adults.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lippi G, Favaloro E, Sanchis-Gomar F. Sudden cardiac and noncardiac death in sports: epidemiology, causes, pathogenesis, and prevention. Semin Thromb Hemost. 2018;44(8):780–6.CrossRefPubMed Lippi G, Favaloro E, Sanchis-Gomar F. Sudden cardiac and noncardiac death in sports: epidemiology, causes, pathogenesis, and prevention. Semin Thromb Hemost. 2018;44(8):780–6.CrossRefPubMed
2.
go back to reference Arora S, Stouffer GA, Kucharska-Newton AM, et al. Twenty-year trends and sex differences in young adults hospitalized with acute myocardial infarction. Circulation. 2019;139(8):1047–56.CrossRefPubMedPubMedCentral Arora S, Stouffer GA, Kucharska-Newton AM, et al. Twenty-year trends and sex differences in young adults hospitalized with acute myocardial infarction. Circulation. 2019;139(8):1047–56.CrossRefPubMedPubMedCentral
3.
go back to reference Lv J, Ni L, Liu K, et al. Clinical characteristics, prognosis, and gender disparities in young patients with acute myocardial infarction. Front Cardiovasc. 2021;8:720378.CrossRef Lv J, Ni L, Liu K, et al. Clinical characteristics, prognosis, and gender disparities in young patients with acute myocardial infarction. Front Cardiovasc. 2021;8:720378.CrossRef
4.
go back to reference Jortveit J, Pripp AH, Langorgen J, Halvorsen S. Incidence, risk factors and outcome of young patients with myocardial infarction. Heart. 2020;106(18):1420–6.CrossRefPubMed Jortveit J, Pripp AH, Langorgen J, Halvorsen S. Incidence, risk factors and outcome of young patients with myocardial infarction. Heart. 2020;106(18):1420–6.CrossRefPubMed
5.
go back to reference Yang J, Biery DW, Singh A, et al. Risk factors and outcomes of very young adults who experience myocardial infarction: the partners YOUNG-MI registry. Am J Med. 2020;133(5):605–12.CrossRefPubMed Yang J, Biery DW, Singh A, et al. Risk factors and outcomes of very young adults who experience myocardial infarction: the partners YOUNG-MI registry. Am J Med. 2020;133(5):605–12.CrossRefPubMed
6.
go back to reference Sagris M, Antonopoulos AS, Theofilis P, et al. Risk factors profile of young and older patients with myocardial infarction. Cardiovasc Res. 2022;118(10):2281–92.CrossRefPubMed Sagris M, Antonopoulos AS, Theofilis P, et al. Risk factors profile of young and older patients with myocardial infarction. Cardiovasc Res. 2022;118(10):2281–92.CrossRefPubMed
7.
go back to reference Qureshi WT, Kakouros N, Fahed J, Rade JJ. Comparison of prevalence, presentation, and prognosis of acute coronary syndromes in ≤35 years, 36–54 years, and ≥55 years patients. Am J Cardiol. 2021;140:1–6.CrossRefPubMed Qureshi WT, Kakouros N, Fahed J, Rade JJ. Comparison of prevalence, presentation, and prognosis of acute coronary syndromes in ≤35 years, 36–54 years, and ≥55 years patients. Am J Cardiol. 2021;140:1–6.CrossRefPubMed
8.
go back to reference Defronzo RA. Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773–95.CrossRefPubMedPubMedCentral Defronzo RA. Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773–95.CrossRefPubMedPubMedCentral
9.
go back to reference Mancusi C, de Simone G, Best LG, et al. Myocardial mechano-energetic efficiency and insulin resistance in non-diabetic members of the strong heart study cohort. Cardiovasc Diabetol. 2019;18(1):56.CrossRefPubMedPubMedCentral Mancusi C, de Simone G, Best LG, et al. Myocardial mechano-energetic efficiency and insulin resistance in non-diabetic members of the strong heart study cohort. Cardiovasc Diabetol. 2019;18(1):56.CrossRefPubMedPubMedCentral
10.
go back to reference Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766.CrossRefPubMed Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766.CrossRefPubMed
11.
go back to reference Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.CrossRefPubMed Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.CrossRefPubMed
12.
go back to reference Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.CrossRefPubMedPubMedCentral Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.CrossRefPubMedPubMedCentral
13.
go back to reference Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76.CrossRefPubMedPubMedCentral Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76.CrossRefPubMedPubMedCentral
14.
go back to reference Liu X, Tan Z, Huang Y, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124.CrossRefPubMedPubMedCentral Liu X, Tan Z, Huang Y, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124.CrossRefPubMedPubMedCentral
15.
go back to reference Zhu Y, Liu K, Chen M, et al. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents. Cardiovasc Diabetol. 2021;20(1):137.CrossRefPubMedPubMedCentral Zhu Y, Liu K, Chen M, et al. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents. Cardiovasc Diabetol. 2021;20(1):137.CrossRefPubMedPubMedCentral
16.
go back to reference Shalaimaiti S, Dai YX, Wu HY, et al. Clinical and genetic characteristics of coronary artery disease in Chinese young adults: rationale and design of the prospective genetic characteristics of coronary artery disease in Chinese young adults (GRAND) study. Cardiol Plus. 2021;6(1):65–72.CrossRef Shalaimaiti S, Dai YX, Wu HY, et al. Clinical and genetic characteristics of coronary artery disease in Chinese young adults: rationale and design of the prospective genetic characteristics of coronary artery disease in Chinese young adults (GRAND) study. Cardiol Plus. 2021;6(1):65–72.CrossRef
17.
go back to reference Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51(3):606.CrossRefPubMed Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51(3):606.CrossRefPubMed
18.
go back to reference Chen C, Lu FC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17(Suppl):1–36.PubMed Chen C, Lu FC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17(Suppl):1–36.PubMed
19.
go back to reference Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(1):2937–44.CrossRefPubMed Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(1):2937–44.CrossRefPubMed
20.
go back to reference Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–212.CrossRefPubMed Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–212.CrossRefPubMed
21.
go back to reference Singh A, Collins BL, Gupta A, et al. Cardiovascular risk and statin eligibility of young adults after an MI: partners YOUNG-MI registry. J Am Coll Cardiol. 2018;71(3):292–302.CrossRefPubMed Singh A, Collins BL, Gupta A, et al. Cardiovascular risk and statin eligibility of young adults after an MI: partners YOUNG-MI registry. J Am Coll Cardiol. 2018;71(3):292–302.CrossRefPubMed
22.
go back to reference Vasques AC, Novaes FS, de Oliveira MS, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–100.CrossRefPubMed Vasques AC, Novaes FS, de Oliveira MS, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–100.CrossRefPubMed
23.
go back to reference Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemichyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51.CrossRefPubMed Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemichyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51.CrossRefPubMed
24.
go back to reference Zhao J, Fan H, Wang T, et al. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc Diabetol. 2022;21(1):123.CrossRefPubMedPubMedCentral Zhao J, Fan H, Wang T, et al. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc Diabetol. 2022;21(1):123.CrossRefPubMedPubMedCentral
25.
go back to reference Park GM, Cho YR, Won KB, et al. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors. Lipids Health Dis. 2020;19(1):7.CrossRefPubMedPubMedCentral Park GM, Cho YR, Won KB, et al. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors. Lipids Health Dis. 2020;19(1):7.CrossRefPubMedPubMedCentral
26.
go back to reference Wu Z, Liu L, Wang W, et al. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study. Cardiovasc Diabetol. 2022;21(1):142.CrossRefPubMedPubMedCentral Wu Z, Liu L, Wang W, et al. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study. Cardiovasc Diabetol. 2022;21(1):142.CrossRefPubMedPubMedCentral
27.
go back to reference Jiao Y, Su Y, Shen J, et al. Evaluation of the long-term prognostic ability of triglyceride-glucose index for elderly acute coronary syndrome patients: a cohort study. Cardiovasc Diabetol. 2022;21(1):3.CrossRefPubMedPubMedCentral Jiao Y, Su Y, Shen J, et al. Evaluation of the long-term prognostic ability of triglyceride-glucose index for elderly acute coronary syndrome patients: a cohort study. Cardiovasc Diabetol. 2022;21(1):3.CrossRefPubMedPubMedCentral
28.
go back to reference Lu YW, Chang CC, Chou RH, et al. Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-lan longitudinal aging study. Cardiovasc Diabetol. 2021;20(1):206.CrossRefPubMedPubMedCentral Lu YW, Chang CC, Chou RH, et al. Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-lan longitudinal aging study. Cardiovasc Diabetol. 2021;20(1):206.CrossRefPubMedPubMedCentral
29.
go back to reference Xu X, Bhagavathula AS, Zhang Y, Ryan PM, Rahmani J, Qi X. Sex differences in the TyG index and cardiovascular risk factors in metabolically obese normal weight phenotype. Int J Endocrinol. 2022;2022:1139045.CrossRefPubMedPubMedCentral Xu X, Bhagavathula AS, Zhang Y, Ryan PM, Rahmani J, Qi X. Sex differences in the TyG index and cardiovascular risk factors in metabolically obese normal weight phenotype. Int J Endocrinol. 2022;2022:1139045.CrossRefPubMedPubMedCentral
30.
go back to reference Wang S, Shi J, Peng Y, et al. Stronger association of triglyceride glucose index than the HOMA-IR with arterial stifness in patients with type 2 diabetes: a real-world singlecentre study. Cardiovasc Diabetol. 2021;20(1):82.CrossRefPubMedPubMedCentral Wang S, Shi J, Peng Y, et al. Stronger association of triglyceride glucose index than the HOMA-IR with arterial stifness in patients with type 2 diabetes: a real-world singlecentre study. Cardiovasc Diabetol. 2021;20(1):82.CrossRefPubMedPubMedCentral
31.
go back to reference Cho YK, Lee J, Kim HS, et al. Triglyceride glucose-waist circumference better predicts coronary calcium progression compared with other indices of insulin resistance: a longitudinal observational study. J Clin Med. 2020;10(1):92.CrossRefPubMedPubMedCentral Cho YK, Lee J, Kim HS, et al. Triglyceride glucose-waist circumference better predicts coronary calcium progression compared with other indices of insulin resistance: a longitudinal observational study. J Clin Med. 2020;10(1):92.CrossRefPubMedPubMedCentral
32.
go back to reference Jin JL, Sun D, Cao YX, et al. Triglyceride glucose and haemoglobin glycation index for predicting outcomes in diabetes patients with new-onset, stable coronary artery disease: a nested case-control study. Ann Med. 2018;50(7):576–86.CrossRefPubMed Jin JL, Sun D, Cao YX, et al. Triglyceride glucose and haemoglobin glycation index for predicting outcomes in diabetes patients with new-onset, stable coronary artery disease: a nested case-control study. Ann Med. 2018;50(7):576–86.CrossRefPubMed
Metadata
Title
Triglyceride-glucose index is associated with severe obstructive coronary artery disease and atherosclerotic target lesion failure among young adults
Authors
Shalaimaiti Shali
Lingfeng Luo
Kang Yao
Xiangdong Sun
Hongyi Wu
Shuning Zhang
Lili Xu
Wei Gao
Jianxuan Li
Juying Qian
Yan Zheng
Yuxiang Dai
Junbo Ge
the GRAND investigators
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2023
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-023-02004-1

Other articles of this Issue 1/2023

Cardiovascular Diabetology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine